On June 3, 2025, Ince & Co. and W&H Law Firm Guangzhou Office jointly conducted a legal compliance training session titled “Regulatory Framework for Offshore, Entrepot Trade, and Cross-border Sales of Pharmaceutical Products in Hong Kong” for Guangzhou Pharmaceutical Holdings Limited (GPHL).
The training was led by Mr. Kevin Woo, Partner at Ince & Co.; Mr. Man Wong, Chief Legal Officer; and Mr. Ye Sigang, Senior Partner at W&H Law Firm. Key participants included members from GPHL’s Legal Department, Business Development Division, and Quality Management Division.
The session provided an in-depth analysis of the legal and regulatory requirements governing offshore pharmaceutical trade, entrepot trade operations, and cross-border sales. Leveraging Ince’s strong expertise in Hong Kong and cross-border legal practice, along with W&H’s deep understanding of China’s pharmaceutical regulations, the speakers outlined critical compliance considerations and risk mitigation strategies tailored to the industry. Attendees showed keen interest and actively engaged in discussions.
To enhance interactivity, the Ince team incorporated a dedicated Q&A and case study segment. Participants raised insightful questions and explored compliance solutions for various business scenarios.



